Global bone growth stimulators market was valued at US $ XX Mn and expected to grow at 5.24% Compound Annual Growth Rate (CAGR) over the 2022 to 2028. Bone growth stimulation (BGS) is a therapy your surgeon may prescribe following a spinal fusion procedure. A bone growth stimulator is a supplemental device worn following cervical (neck) or lumbar (low back) spine surgery. BGS may be utilized to help spinal bone fuse after a fusion procedure or as a treatment for failed fusion. Due to a sharp drop in elective surgeries, a ban on organised sports, the temporary closure of O&P clinics, hospital access restricted to non-essential care, limited access to clinics, and slowed in-patient flow and referrals, the pandemic is expected to have a short-term negative impact on the bone growth stimulators market. The market is expected to gradually rise starting in the late second half of 2021, which could be attributed to addressing pre-COVID elective surgeries, an increase in the number of surgeries as a result of clearing backlogs as well as new cases, fully reopened healthcare services, large-scale recreation and physical work, and the reopening of organised sports. Long-term growth drivers such as the growing senior population and the rising prevalence of diabetes, obesity, and osteoarthritis will also continue to fuel the market’s expansion over the forecast period.